A recent posting on a pharmaceutical information website has called into question the Food and Drug Administration’’s claims that name-brand drugs and their generic equivalents are "identical," instead claiming that there are notable differences between the two.
"What the FDA does not tell you in this sentence is that generic drugs can have different ”inert” ingredients or fillers," read a recent article on PeoplesPharmacy.com. "In other words, all the other stuff except the active ingredient could be completely different."
In order to substantiate their claim, the website dissected the differences between the brand-name antidepressant drug Wellbutrin XL 300 and its generic equivalent Budeprion XL 300 – which had received a number of complaints from its users regarding its effectiveness.
While Wellbutrin XL 300 used "membrane" technology for the slow release of bupropion – the drug’s active ingredient – the posting added that the Food and Drug Administration had confirmed that Budeprion XL 300 used a different "matrix" technology that released the active ingredient in a much shorter time span.
The website added that it had received complaint regarding many other generic drugs in comparison to their name-brand alternatives from its readers, including the heart drug Toprol XL (and its generic equivalent metoprolol succinate) and pain reliever OxyContin (oxycodone).
For consumers who are in need of a prescription medication that needs to work exactly as advertised in order to remain healthy but are short on finances, taking out a payday loan in order to afford the name-brand drug instead of a perhaps-questionable alternative may be a safe move to ensure that one remains healthy.
Make Anyday Payday
